Livanova

Global medical technology company

Livanova logo
1001+ employees
  • Healthcare
  • B2B
  • Science
  • MedTech
Paddington, London, UK

Jump to section

Company mission

To provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart.

Our take

LivaNova creates advanced medical devices and treatments in areas like cardiopulmonary care and neuromodulation, helping both patients and healthcare professionals worldwide. With its diverse range of products and a presence in over 100 countries, it is a leader in this field, striving to improve the lives of those who need it most.

Officially founded in 2015, the company's history actually stretches back to the founding of Sorin Biomedica in 1956. LivaNova was founded from the merging of Sorin with Cyberonics, which is how it came to be at the forefront of innovation in both cardiovascular disease and neuromodulation.

One of the company's breakthrough treatments is for obstructive sleep apnea (OSA), a condition where breathing stops and starts during sleep. Its device, the aura6000, earned FDA approval in 2026. This opens up the opportunity for LivaNova to become a major competitor in the sleep apnea market, positioning it for exciting growth in an expanding field.

Kirsty headshot

Kirsty

Company Specialist at Welcome to the Jungle

Leadership

Vladimir Makatsaria

(CEO)

Previously spent over 27 years at Johnson & Johnson, while there they served in various roles, including Company Group Chairman of Ethicon Global Business, Chairman of China, and Global Integration Leader among other roles.